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Abstract 
Background: Injection of fibrin glue mixed with blood into the epidural space to reliably and effectively treat medi-
cally refractory orthostatic headache caused by spinal cerebrospinal fluid (CSF) leaks and subsequent intracranial 
hypotension has recently been described. The study described in this article utilizes an analogous technique to gauge 
the therapeutic reproducibility of this novel technique.
Methods: Eight patients with medically refractory headache resulting from intracranial hypotension caused by spinal 
CSF leaks received epidural injections of combined fibrin glue, autologous blood, and Isovue contrast at the L1—2 
vertebral level using intermittent fluoroscopic guidance. Pre-procedure, 1-week post-procedure, and 3-month post-
procedure headache pain scores were collected and used for comparison.
Results: Three out of 8 patients reported relief at 1 week, although 1 of these 3 patients had returned to their base-
line pain intensity at 3 months. Four patients reported no change at 1 week, though 2 of these patients had reduction 
of their chronic headache pain at 3 months. A single patient reported increased pain 1 week after the procedure, 
which persisted at 12 weeks. Overall, 4 out of the 8 patients had decreased pain scores at 3-month follow-up.
Conclusions: We did not achieve a similar frequency of headache resolution as reported in prior original studies. 
However, a subset of patients did appear to receive substantial benefit from the combined fibrin glue-blood patching 
procedure. This technique may prove to be useful in medically refractory cases, including those patients who con-
tinue to have symptoms despite the prior administration of conventional epidural blood patches.
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Background
Headache associated with spontaneous intracranial 
hypotension (SIH) is often although not always ortho-
static (provoked or aggravated in upright position and 
decreased or relieved in recumbency). The diagnosis 
is made based on the synthesis of patient history, clini-
cal findings, cerebrospinal fluid (CSF) examination, and 
imaging studies. These headaches, which are now well 
defined in the scientific literature, can be frontal, occipi-
tal, frontooccipital or holocephalic in anatomic location 
(Scott and Davenport 2014; Mokri 2014). They are often 
pressure-like, occasionally throbbing, and typically bilat-
eral. With chronicity the orthostatic features of the head-
ache may dampen and they may transform into chronic 
daily headaches. In some cases the headaches are exer-
tional or may even have thunderclap onset before ortho-
static features arise (Spears 2014). Other symptoms that 
are frequently encountered with the headache include 
neck or interscapular pain, cochleovestibular symptoms 
(tinnitus, changes in hearing, dizziness), nausea, eme-
sis, diplopia, mild unsteadiness, memory deficiencies, 
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personality changes and a variety of less common man-
ifestations; giving rise to a broad spectrum of clini-
cal presentation that can be quite different from classic 
post dural puncture headaches (Scott and Davenport 
2014; Mokri 2014; Spears 2014). CSF opening pressure 
is often low or borderline but may also be normal. Head 
magnetic resonance imaging (MRI) typically shows dif-
fuse pachymeningeal gadolinium enhancement without 
leptomeningeal enhancement (Mokri 2014; Mitsikostas 
et al. 2015). Additionally, imaging often reveals evidence 
of sinking of the brain (descent of cerebellar tonsils and 
brainstem, crowding of the posterior fossa), subdural 
fluid collections and pituitary engorgement with enlarge-
ment. It is now recognized that nearly all cases of SIH 
result from spontaneous CSF leaks, which occur at the 
level of the spine (Inamasu and Guiot 2006). Spontane-
ous CSF leak at the level of skull base does occur but 
only rarely. Evidence of spinal CSF leak may be shown by 
spine MRI, computed tomography myelography (CTM), 
or both. In select cases with slow CSF leaks, gadolinium 
myelography may be helpful (GdM; spine MRI after 
intrathecal injection of gadolinium). Radioisotope cis-
ternography may also show the site of CSF leakage, but 
is considered to be less sensitive than CTM. The precise 
etiology of spontaneous (non-traumatic) CSF leaks is 
often unclear, but it is now increasingly recognized that 
some of these patients show evidence of disorder of con-
nective tissue matrix leading to dural weakness that can 
predispose to spontaneous leaks (Mokri 2014; Schrijver 
et al. 2002).
Epidural blood patch (EBP) has emerged as the treat-
ment of the choice for patients who fail initial conserva-
tive management. The mechanism of action for blood 
patching is twofold, with both immediate and delayed 
effects. The immediate effect results from tamponade 
of the dural sac (by injected epidural blood), leading to 
translocation of axial CSF to the intracranial compart-
ment and subsequent increased CSF pressure. Delayed 
effects are attributed to actual sealing of the leakage 
site, which allows the intrathecal space to be reconsti-
tuted with normal volume as CSF is naturally regener-
ated and recirculated. Previous studies have pointed to 
success rates ranging from 36 to 85 % after a single epi-
dural blood patch for SIH headaches (Sencakova et  al. 
2001; Gaukroger and Brownridge 1987; Berroir et  al. 
2004). Those who do not respond to epidural blood patch 
are typically considered to have refractory headaches, 
although the exact definition of refractory headache has 
not yet been agreed upon by the medical community 
(Lampl et al. 2014). Fibrin glue has also been used as an 
alternative to blood, particularly in cases where the use of 
autologous blood has not been feasible, when a smaller 
volume of epidural injection is preferred, or when the 
leak has persisted despite trials of multiple EBPs. Several 
studies and reports have confirmed efficacy of epidural 
fibrin glue injection, without the addition of additional 
blood (Schievink 2008; Patel et al. 1996).
Two studies (Franzini et al. 2010, 2013) have proposed 
epidural injections of fibrin glue mixed with blood as an 
effective method to reliably treat medically refractory 
orthostatic headaches caused by intracranial hypoten-
sion. In a study published in 2010 (Franzini et  al. 2010) 
involving 28 patients, at 3  months follow-up 70  % were 
headache free and 22  % complained of only sporadic 
headaches. In a study published in 2013 (Franzini et  al. 
2013), there were 80 patients with 3  months follow-up. 
After a single procedure, 87  % reported complete reso-
lution of their symptoms. The non-responders then 
received a second epidural patch, and a total of 90 % of 
patients reported complete resolution of symptoms at 
3 months. The aim of our study was to assess the over-
all efficacy of EBP plus fibrin glue additive and attempt to 
reproduce the results of these prior studies.
Methods
Following IRB approval from our institution, we enrolled 
8 patients—5 females and 3 males—with refractory 
headaches related to SIH or dural puncture and treated 
them with epidural injections of blood with fibrin glue 
at the L1 spine level. Refractory headaches were defined 
as those with symptoms that had failed to resolve with 
at least one prior epidural blood patch performed using 
traditional technique with fluoroscopic guidance. Each 
patient also had neurologic evaluation by a neurologist 
prior to the epidural injection with confirmation of the 
diagnosis of refractory headache caused by intracra-
nial hypotension. Using the numeric rating scale (NRS), 
pre-procedure and 1  week post-procedure headache 
pain scores were collected and available to review via 
electronic medical records. The patients were contacted 
via telephone at 3-month post-procedure and headache 
pain scores were recorded at that time. Patients were also 
questioned about duration of pain relief and functional 
improvement after receiving the fibrin glue blood patch. 
To further assess patient satisfaction, they were also 
asked if they would recommend this procedure to others 
or if they would be willing to undergo a repeat procedure. 
Mean and median NRS score were graphed to compare 
changes (see Fig. 1).
The fibrin glue sealant, Baxter Tisseel©, was used due 
to its similarity to the fibrin product used in 2 previous 
publications (Franzini et  al. 2010, 2013). Our protocol 
also required fluoroscopically accessing the L1—2 epi-
dural space with an 18 gauge Tuohy needle (using a mid-
line, interlaminar approach). Needle placement was then 
confirmed with Isovue contrast administration, in both 
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the lateral and anterior-posterior fluoroscopic views. 
Next, 10 ml of autologous blood was sterilely withdrawn 
from the patient and briefly set aside after mixing the 
obtained blood with 3 ml of additional Isovue contrast. 
The Tisseel© syringe was attached to extension tubing 
connected to the Tuohy epidural needle hub, and fibrin 
glue was then injected rapidly into the posterior epidural 
space until a pressure paresthesia of at least 2–3 out of 
10 intensity or greater was experienced by the patient. 
Note that pressure paresthesia was defined as signifi-
cant pressure sensations felt by the patient in the head, 
back, buttock or legs (whether unilateral or bilateral). 
Up to 10 ml of fibrin glue injectate was available to inject 
(the full capacity of the Tisseel© syringe), although the 
actual fibrin glue volume utilized was dependent upon 
the onset and intensity of patient paresthesia response 
alone (i.e., fibrin glue was injected until the patient 
experienced this paresthesia response). Thereafter, the 
previously prepared blood-Isovue mixture was injected 
immediately afterward through a new connection tube. 
Only enough blood mixture was injected to clear the 
epidural needle from fibrin glue (less than 1  cc), while 
immediately ceasing further injection until the patient’s 
pressure paresthesia had fully resolved to its pre-pro-
cedural baseline. Once the patient’s paresthesia had 
fully resolved, additional blood-Isovue admixture was 
injected until the patient again experienced a pressure 
paresthesia of at least 2–3 out of 10 intensity. The epi-
dural needle was then gently flushed with saline or 1 % 
lidocaine as it was withdrawn from the epidural space 
and fully removed from the skin. Patients were asked 
to remain supine in our recovery area for about 30 min 
post-procedurally to allow further stabilization of the 
injectate in the epidural space.
Results
Each of our 8 patients reported pain scores using the 
NRS system at three time points (Table 1). Three patients 
reported relief at 1 week, however only 1 patient in that 
group experienced greater than 50 % relief. Four patients 
reported no change at 1 week, though 2 of these patients 
had reduction of their chronic headache pain when fur-
ther assessed at 3 months. A single patient reported a 3 
point increase in pain after the procedure, which per-
sisted at the 12-week follow-up. Of the patients who had 
immediate post-procedure relief (3), only 1 patient had 
worsening of pain back that returned to baseline intensity 
at 3  months (others maintained benefit or had further 
pain attenuation at 3 months). Also at 3 months, 50 % of 





















Fig. 1 Mean pre-/post-procedure pain scores. Shown are mean ± standard error of the mean (SEM) NRS pain scores at the noted time points. 
Statistical analysis (two-tailed Student’s t test) revealed no significant difference in mean pain score between pre-procedure and 1-week post-
procedure or between pre-procedure and 3-week post-procedure. Median pain scores for each group were 8.5, 7.5, and 7 for pre-procedure, 1-week 
post-procedure, and 3-week post-procedure, respectively
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to experience the same level of discomfort while the 
other 50 % reported a significant reduction or even reso-
lution of their symptoms. Two patients underwent a sec-
ond fibrin glue blood patch procedure.
In summary, overall there was a slight trend down-
wards in mean and median pain scores 1 week post-pro-
cedure as compared to pre-procedural baseline (Fig.  1). 
At 3  months post-procedure, 4 out of 8 patients had 
decreased pain scores.
Discussion
The purpose of our study was to evaluate the efficacy of 
epidural injection of combined fibrin glue and blood to 
treat medically refractory low CSF pressure, low volume 
headaches. In contrast to the previous original reports 
(Franzini et al. 2010, 2013) we encountered several chal-
lenges with the procedure itself and also did not achieve 
similar results, at least in terms of frequency of headache 
resolution.
It has been theorized by one group that negative pres-
sure in the epidural space occurs with standing, resulting 
in aspiration of CSF into the epidural veins and back to 
the vena cava system which facilitates a physiologic state 
of prolonged intracranial hypotension (Franzini et  al. 
2010, 2013). Similarly unsubstantiated, it has been fur-
ther theorized by the same group that combining fibrin 
glue with autologous blood may allow for a reversal in 
this flow gradient. In a 2010 study published by Franzini 
et al. involving 28 patients, 70.4 % (19/27) success rate at 
3 months, 81.8 % (18/22) success rate at 1 year, and 83.8 % 
(10/11) success rate at 3  years were reported (Franzini 
et al. 2010). A study published in 2013 by Franzini et al. 
found complete symptom resolution in 87  % of an 80 
patient cohort at 3 months after a single injection (Fran-
zini et al. 2013). Those who had not responded received a 
second epidural injection and collectively a success rate 
of 90 % was reportedly encountered.
The patients in our study did not achieve nearly the 
same level of success, although a subset of the patients did 
appear to receive substantial benefit from the combined 
fibrin glue-blood patching procedure. While no patients 
had complete resolution of their headache 1  week after 
the injection, 3 of the 8 patients (37.5 %) did report some 
pain relief at 7 days. At 3-month follow-up, only 1 patient 
(12.5 %) had complete resolution of her headache, while 
an additional 3 (37.5 %) had prolonged partial resolution 
of their symptoms. Unfortunately, 1 patient (12.5 %) had 
prolonged increased pain after the procedure that per-
sisted at 3-month follow-up. While our results were not 
as encouraging as those of prior reports, they do indicate 
that the combined blood and fibrin glue patch may prove 
beneficial in a subset of medically refractory patients who 
have failed conservative treatments and conventional 
EBPs.
The small sample size is a limitation of our study. A 
study involving a larger number of patients is under-
way. Of significant note, we were not able to reproduce 
the exact procedural protocol of prior original studies 
(Franzini et  al. 2010) in which 5  mL autologous blood, 
5  mL fibrin glue and 3  mL Isovue were described as 
Table 1 Patient information, history, and pre-/post-procedure pain scores
CSF cerebrospinal fluid, F female, M male
a Pain scores are on a scale from 1 to 10
Case  
number










1 F Orthostatic, exertional,  
and valsalva headache
2 6 9 9
2 F Intracranial hypotension 
headache
1 10 10 10
3 F Intracranial hypotension 
headache
1 9 6 6
4 M Spontaneous CSF leak  
with headache
2 9 9 9
5 M Intracranial hypotension 
headache
1 8 3 8
6 F Intracranial hypotension 
headache
1 9 9 3
7 M Intracranial hypotension 
headache
1 7 5 2
8 F Intracranial hypotension 
headache
1 3 3 0
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being combined within a single syringe prior to injection 
into the epidural space at L1—2. We found that contact 
between blood and fibrin glue in a single syringe caused 
fairly immediate clotting with formation of a pasty com-
pound, which precluded further injection. To overcome 
this procedural limitation we modified the protocol to 
allow injection of fibrin glue first, followed by an injection 
of autologous blood mixed with contrast. This resulted in 
a similar total volume and fibrin glue-to-blood ratio.
Conclusions
We noted some benefit for some patients from the injec-
tion of both fibrin glue and autologous blood into the 
epidural space. We are hesitant to advocate the regular 
use of this technique for all patients with SIH headaches 
because of the expense, efficacy, and possibility of side 
effects of this technique in the setting of only modest 
expected efficacy. However, this procedure may prove to 
be useful in refractory cases. A pre-procedure discussion 
of the risks and benefits is warranted.
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